V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320006712 | 320005925 | 1.8 | 80.5 | Palliative (P) | 2018-11-02 | 2018-11-02 | Carboplatin + Docetaxel | Y | N | 320013895 | CETUXIMAB + CISPLATIN + FU |
| 320006713 | 320004202 | 1.76 | 64.6 | Curative (C) | 2017-02-17 | 2017-02-18 | Trastuzumab Subcutaneous | 02 | N | 320015394 | NIRAPARIB |
| 320006714 | 320004202 | 1.55 | 53.4 | Palliative (P) | 2018-01-29 | 2018-02-05 | Carboplatin + Cetux + FU (>Cycle 2) | 2 | N | 320015394 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320006715 | 320004203 | 1.71 | 112.8 | Curative (C) | 2017-04-10 | 2017-05-11 | Carbo F | N | N | 320015925 | CETUXIMAB + CISPLATIN + FU |
| 320006716 | 320004206 | null | 57.6 | Palliative (P) | 2017-01-20 | 2017-02-19 | IMATINIB | N | N | 320016064 | BCG |
| 320006717 | 320004207 | 1.7 | 71.4 | Palliative (P) | 2017-08-09 | 2017-08-25 | ECX | N | N | 320016619 | CARBOPLATIN + RT |
| 320006718 | 320004211 | 1.67 | 69 | Palliative (P) | 2017-11-10 | 2017-11-11 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | Y | 320017340 | POUT TRIAL |
| 320006719 | 320004212 | null | 65.5 | Palliative (P) | 2017-06-08 | 2017-06-08 | BEVACIZUMAB + CARBO + PACLITAXEL | 2 | Y | 320017413 | FLUOROURACIL + MITOMYCIN + RT |
| 320006720 | 320005934 | 1.64 | 59.9 | Palliative (P) | 2016-07-08 | 2016-08-10 | CNS LGG Bevacizumab & Irinotecan | N | N | 320018048 | NIRAPARIB |
| 320006721 | 320005935 | 1.52 | 62.4 | Palliative (P) | 2016-12-24 | 2016-12-27 | CARBOPLATIN + RT | N | N | 320018267 | ICON TRIAL |
| 320006722 | 320004218 | 1.54 | 80.8 | Palliative (P) | null | 2018-01-29 | CETUXIMAB + RT | N | N | 320018367 | CAV |
| 320006723 | 320005936 | 1.84 | 79.6 | Curative (C) | 2015-08-12 | 2015-09-08 | IMATINIB | N | N | 320018779 | CARBOPLATIN + ETOPOSIDE |
| 320006724 | 320004225 | 1.82 | null | Curative (C) | 2015-07-28 | 2017-08-29 | Docetaxel | N | N | 320018852 | CETUXIMAB + CISPLATIN + FU |
| 320006725 | 320004227 | null | 93.4 | Palliative (P) | 2014-12-31 | 2016-04-16 | PEMBROLIZUMAB | N | N | 320019034 | AFLIBERCEPT + FU + IRINOTECAN |
| 320006726 | 320004231 | 1.69 | 50.25 | Palliative (P) | 2016-01-11 | 2016-01-29 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 320019154 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320006727 | 320005941 | 1.42 | 54.8 | Curative (C) | 2016-02-11 | 2016-04-24 | TEMOZOLOMIDE | 02 | N | 320019368 | EVEROLIMUS |
| 320006729 | 320004237 | 1.69 | 98 | Palliative (P) | 2018-11-03 | 2018-11-11 | Irinotecan + Modified De Gramont | 02 | N | 320019483 | DOCETAXEL |
| 320006730 | 320004238 | 1.54 | 61 | Curative (C) | 2016-08-05 | 2016-08-13 | Temozolomide 200mg/m2 | N | N | 320019595 | CETUXIMAB + RT |
| 320006731 | 320004242 | 1.79 | null | Palliative (P) | null | 2018-03-27 | Atezolizumab | N | N | 320021199 | CARBOPLATIN + ETOPOSIDE |
| 320006732 | 320004245 | null | 70 | null | 2018-01-10 | 2018-01-10 | CNS LGG Bevacizumab & Irinotecan | 02 | N | 320021311 | PEMBROLIZUMAB |
| 320006733 | 320004248 | 1.72 | null | Palliative (P) | 2017-06-28 | 2017-07-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320021327 | CARBOPLATIN + RT |
| 320006734 | 320004249 | 0 | null | Palliative (P) | 2016-06-30 | 2016-06-30 | BCG Intravesical | 02 | Y | 320021379 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320006735 | 320004252 | 1.77 | 57.6 | Curative (C) | 2017-06-06 | 2017-06-08 | Cisplatin + Vinorelbine (IV) | N | N | 320021389 | CETUXIMAB + RT |
| 320006736 | 320004254 | null | 97 | Palliative (P) | 2016-08-23 | 2016-08-25 | AFLIBERCEPT + FU + IRINOTECAN | 2 | N | 320021396 | CETUXIMAB + RT |
| 320006737 | 320004256 | 1.86 | 77.4 | Palliative (P) | 2015-07-09 | 2015-07-11 | TEMOZOLOMIDE | 2 | N | 320021407 | PEMBROLIZUMAB |
| 320006738 | 320004257 | 1.53 | 80.35 | Palliative (P) | null | 2017-09-08 | IMATINIB | N | N | 320021412 | BEVACIZUMAB + CARBO |
| 320006739 | 320004258 | 1.62 | 75.15 | Palliative (P) | 2017-03-21 | 2018-04-19 | Niraparib | 2 | N | 320021413 | VAI |
| 320006740 | 320004260 | 1.62 | 74.1 | Disease modification (D) | 2018-09-19 | 2018-09-28 | Doxorubicin 75mg/m2 | N | N | 320021426 | VINBLASTINE |
| 320006741 | 320005954 | null | null | Palliative (P) | 2015-07-29 | 2015-11-18 | Docetaxel | 02 | null | 320021540 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 320006742 | 320004265 | 1.84 | 96.5 | Palliative (P) | 2019-02-07 | 2019-02-07 | PCV | Y | N | 320021548 | CAPECITABINE + CISPLATIN |
| 320006743 | 320004267 | 1.49 | null | Palliative (P) | 2018-12-30 | 2019-04-20 | Paclitaxel albumin (Abraxane) 21day | N | N | 320021588 | DOXORUBICIN |
| 320006744 | 320004269 | 1.76 | 97 | Palliative (P) | 2019-10-24 | 2019-10-25 | CAPECITABINE + CETUXIMAB + CISPLATIN | 2 | N | 320021762 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 320006745 | 320005958 | 1.62 | 69 | Palliative (P) | 2014-06-27 | 2014-06-27 | Docetaxel | N | N | 320021777 | BCG |
| 320006746 | 320006762 | 1.7 | null | null | 2016-03-15 | 2016-03-30 | Capecitabine + Cisplatin | null | null | 320021788 | VEMURAFENIB |
| 320006747 | 320004273 | 1.56 | 75 | null | 2016-08-15 | 2016-08-29 | NIVOLUMAB | N | N | 320021893 | NAB-PACLITAXEL |
| 320006748 | 320004275 | 1.55 | 95 | Adjuvant (A) | 2014-05-04 | 2014-05-04 | Cetuximab + Radiotherapy Maint | N | N | 320021893 | POUT TRIAL |
| 320006749 | 320005961 | 1.7 | 99.2 | Palliative (P) | 2018-04-02 | 2018-04-03 | IVADo | N | N | 320022034 | TEMOZOLOMIDE |
| 320006750 | 320006765 | 1.8 | 105.9 | Curative (C) | 2015-07-11 | 2015-07-11 | EOX | 02 | N | 320022127 | CETUXIMAB + RT |
| 320006751 | 320006766 | null | 64.2 | Not known (9) | 2016-03-16 | 2016-07-20 | Cisplatin + Vinorelbine (IV) | 02 | N | 320022208 | CISPLATIN + PACLITAXEL |
| 320006752 | 320007403 | 1.66 | 88.6 | Curative (C) | 2015-01-07 | 2015-04-02 | CNS LGG 2004 03 vinc weekly+ carbo | N | Y | 320022270 | CAV |
| 320006753 | 320004280 | 1.74 | 62 | null | null | 2017-09-07 | CARBOPLATIN + RT | N | N | 320022352 | TRIFLURIDINE + TIPIRACIL |
| 320006754 | 320004280 | 1.7 | null | Palliative (P) | 2015-08-18 | 2015-08-19 | IMATINIB | 2 | N | 320022352 | LOMUSTINE + PROCARBAZINE |
| 320006755 | 320007404 | 1.67 | 86 | Palliative (P) | 2017-09-13 | 2017-09-29 | CNS LGG 2004 03 vinc weekly+ carbo | N | N | 320022496 | NIVOLUMAB |
| 320006756 | 320005968 | 1.85 | null | Neo-adjuvant (N) | 2016-12-30 | 2017-01-06 | CARBOPLATIN + Cetuximab + FLUOROURACIL | Y | N | 320023410 | CARBO + FLUOROURACIL |
| 320006757 | 320005968 | 1.7 | 109.6 | Palliative (P) | 2018-09-22 | 2018-10-07 | Cisplatin + Fluorouracil + RT 5day | Y | null | 320023410 | PEMBROLIZUMAB |
| 320006758 | 320005969 | 1.71 | null | Adjuvant (A) | 2017-02-21 | 2017-03-04 | ICON8 TRIAL | N | null | 320023822 | VINBLASTINE |
| 320006759 | 320004289 | 1.71 | 88.6 | Curative (C) | 2017-06-09 | 2017-06-09 | TCF | null | null | 320023932 | CAPECITABINE |
| 320006760 | 320004292 | 1.83 | 83.7 | Palliative (P) | 2015-08-10 | 2015-08-11 | TEMOZOLOMIDE | N | N | 320025110 | CARBO + FLUOROURACIL |
| 320006761 | 320004294 | 1.54 | 60.9 | Adjuvant (A) | 2016-02-23 | 2018-03-30 | CHOP R - 21 days | N | N | 320004814 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320006762 | 320006771 | 1.63 | 102.7 | Palliative (P) | 2018-08-04 | 2018-08-06 | VINCRISTINE | 02 | N | 320005218 | OCTOPUS TRIAL |